Tue, May 13, 2025
Mon, May 12, 2025
Sun, May 11, 2025
Sat, May 10, 2025

Sight Sciences, Inc. (SGHT) Q1 2025 Earnings Call Transcript

  Copy link into your clipboard //science-technology.news-articles.net/content/2 .. s-inc-sght-q1-2025-earnings-call-transcript.html
  Print publication without navigation Published in Science and Technology on by Seeking Alpha
          🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source
Sight Sciences, Inc. (NASDAQ:SGHT) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ETCompany ParticipantsHannah Jefferies - Investor RelationsPaul...
Sight Sciences Inc. (SGHT) reported its Q1 2025 earnings, highlighting a revenue increase to $20.5 million, up 14% year-over-year, driven by strong growth in Surgical Glaucoma and Dry Eye segments. The company's net loss widened to $16.9 million from $14.7 million in the previous year, attributed to increased operating expenses. Sight Sciences also discussed progress in its product pipeline, including the ongoing enrollment for the SAHARA trial for its OMNI® Surgical System and the launch of the SION™ Surgical Instrument. The company remains focused on expanding its market presence and advancing its technology to address unmet needs in eye care, with a reaffirmed full-year revenue guidance of $84 million to $87 million.

Read the Full Seeking Alpha Article at:
[ https://seekingalpha.com/article/4785128-sight-sciences-inc-sght-q1-2025-earnings-call-transcript ]